OSTEOGENEX, INC

Address

PO Box 3132
Kansas city, KS, 66103-

Information

DUNS: 167266555
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y

Award Charts




Award Listing

  1. Oral delivered bone building therapy for osteoporosis

    Amount: $475,076.00

    DESCRIPTION (provided by applicant): The osteoporosis market is still in demand for new therapeutics due to the lack of safe orally available bone building drugs. Currently, parathyroid hormone (PTH; ...

    SBIRPhase I2013Department of Health and Human Services
  2. Anabolic Therapeutics for Increasing Bone Denisty and Quality

    Amount: $994,943.00

    DESCRIPTION (provided by applicant): OsteoGeneX is developing a therapeutic directed against the new bone target Sclerostin (SOST) for the treatment of osteoporosis and related bone disorders. Throug ...

    SBIRPhase II2008Department of Health and Human Services
  3. Therapeutics for increasing Bone Density and Quality

    Amount: $133,904.00

    DESCRIPTION (provided by applicant): Osteoporosis affects 55% of Americans over the age of 50, and incurs a medical cost of $47 million a day. It is caused by a disruption in the fine equilibrium betw ...

    SBIRPhase I2006Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government